AI in healthcare is moving from promise to practice as multiple states in India roll out new tech-driven initiatives to improve diagnosis, training, and patient care. In Madhya Pradesh, the state government has launched a pilot program across 10...
In a major boost to robotic cardiac surgery, Apollo Hospitals, Jubilee Hills, has completed 100 assisted robotic cardiac surgeries in just 155 days using the da Vinci Surgical System. The achievement highlights how fast advanced, minimally...
India has taken an important step to bring more clarity and consistency to its medical devices sector by introducing a standardised testing fee framework. The move is expected to make the system more transparent, predictable, and affordabl...
Punjab is moving ahead with its plan to expand primary healthcare through pind clinics, with Health Minister Dr Balbir Singh confirming that 1,100 pind clinics will be launched in the first phase. The state aims to scale this up to 2,500...
India’s vaccine testing shift to govt labs only is making waves today, with the Centre moving to restrict testing of vaccines and biological products to government facilities. The proposed shift in vaccine testing aims to tighten oversight...
The Lupin Human Welfare & Research Foundation has taken another important step to improve healthcare access in Rajasthan by introducing new diagnostic facilities focused on non-communicable diseases (NCDs). This initiative aims to make earl...
In a major move, Redcliffe Labs divests Crysta IVF to Moon Care, the healthcare arm of MMG Group, reinforcing its focus on diagnostics. This Redcliffe Labs divests Crysta IVF deal highlights the company’s preventive-first strategy and sharper...
Jharkhand’s Health Minister Irfan Ansari on Wednesday announced the Jharkhand health cottages plan, a major step to boost rural healthcare by setting up health cottages in every panchayat.
Biocon Biologics, a subsidiary of Biocon, has launched its denosumab biosimilars—Bosaya and Aukelso—in the US market, marking an important milestone in the company’s global expansion journey.
French drugmaker Sanofi has shared positive results from its phase 2 clinical trials of lunsekimig, an experimental treatment aimed at chronic respiratory diseases such as asthma and chronic rhinosinusitis with nasal polyps (CRSwNP).
.jpg)
.jpg)
, CDSCO.jpg)